S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
NASDAQ:NVDQ

(NVDQ) (NVDQ) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$4.71
$5.22
50-Day Range
N/A
52-Week Range
$5.84
$12.74
Volume
3.47 million shs
Average Volume
797,205 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NVDQ stock logo

About (NVDQ) Stock (NASDAQ:NVDQ)

NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.

NVDQ Stock News Headlines

T-Rex 2X Inverse NVIDIA Daily Target ETF (NVDQ)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
O'Keefe Stevens Advisory - Nvidia: The End Of An Era?
New Tesla, Nvidia ETFs Offer 200% Leverage
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Novadaq Technologies Inc.(NVDQ)
Arrow Explor. Regulatory News
See More Headlines
Receive NVDQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NVDQ) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/03/2017
Today
4/18/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:NVDQ
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • William A. MacKinnon
    Chairman of the Board
  • Rick Mangat Ph.D.
    President, Chief Executive Officer

  • Bio & Compensation - 
  • Roger Deck
    Chief Financial Officer

  • Bio & Compensation - 
  • Lori Swalm
    Vice President of Marketing

  • Bio & Compensation - 
  • Derrick Guo
    General Counsel, Corporate Secretary

  • Bio & Compensation - 
  • Anthony F. Griffiths
    Lead Independent Director
  • Lisa N. Colleran
    Director
  • Karen A. Licitra
    Director

  • Bio & Compensation - 
  • Patrice E. Merrin
    Independent Director
  • Thomas G. Wellner
    Independent Director

NVDQ Stock Analysis - Frequently Asked Questions

How were (NVDQ)'s earnings last quarter?

(NVDQ) (NASDAQ:NVDQ) announced its quarterly earnings data on Wednesday, May, 3rd. The medical research company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.03. The medical research company earned $21.08 million during the quarter, compared to analysts' expectations of $20.12 million.

How often does (NVDQ) pay dividends? What is the dividend yield for (NVDQ)?

(NVDQ) declared a dividend on Friday, December 22nd. Investors of record on Wednesday, December 27th will be given a dividend of $1.80 per share on Thursday, December 28th. The ex-dividend date is Tuesday, December 26th.
Read our dividend analysis for NVDQ
.

What other stocks do shareholders of (NVDQ) own?
This page (NASDAQ:NVDQ) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners